NEWS | alsv | Page 5 of 17

Companies in the News

Nuvation Bio Granted Orphan Drug Designation for NUV-422 for Patients with Malignant Gliomas

NEW YORK, March 11, 2021 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet...

Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early Treat

Independent Data Monitoring Committee recommends stopping Phase 3 COMET-ICE trial early given an 85% reduction in hospitalization or...

GlaxoSmithKline doubles down on Vir pact, throwing in $345M upfront to go beyond COVID-19

Last year, Big Pharma GlaxoSmithKline and George Scangos’ biotech Vir joined forces against COVID-19. Now, the pair is turning its...

Nuvation Bio Closes Transaction with Panacea, Debuts as Publicly Traded Oncology Company

Combined company renamed Nuvation Bio Inc., will be listed on the New York Stock Exchange under ticker symbol "NUVB" Strong cash position...

Sana snags $587.5M IPO to catapult cell therapies into the clinic

Massive private raise? Check. Preclinical pipeline? Check. Now, Sana Biotechnology is raising $587.5 million in a mammoth IPO that will...

Gilead Sciences and Gritstone Announce Collaboration For HIV Cure

FOSTER CITY, Calif. and EMERYVILLE, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Gilead Sciences, Inc. (Nasdaq: GILD) and Gritstone...

Gritstone Advances Second Generation COVID-19 Vaccine “CORAL” Program with Support from NIAID

EMERYVILLE, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company...

Tessera Therapeutics Attracts Over $230M in Series B Financing to Advance ‘Gene Writing’

SoftBank Vision Fund 2, Alaska Permanent Fund Corporation, Altitude Life Science Ventures, Qatar Investment Authority, and Other New...

Top Life Sciences Startups to Watch in 2021

BioSpace is proud to present its NextGen Bio “Class of 2021,” a list of up-and-coming life sciences companies in North America that...